Stereotactic Ablative Radiation

RADIATION2 trials

Sponsors

Sunnybrook Health Sciences Centre, University of Texas Southwestern Medical Center

Conditions

Prostate AdenocarcinomaUrothelial Cancer

Phase 1

Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer

Sunnybrook Health Sciences CentreProstate Adenocarcinoma

Start: 2014-01-31End: 2024-09-12Target: 30Updated: 2020-11-24

Phase 2

Stereotactic Ablative Radiation for Oligo-Progression of Urothelial Cancer

TerminatedNCT04131634

University of Texas Southwestern Medical CenterUrothelial Cancer

Start: 2020-01-16End: 2021-06-10Updated: 2021-06-16

Related Papers

Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer.

2023-08-226 citations

To Boost or Not to Boost: Pooled Analyses From 2-Fraction SABR Trials for Localized Prostate Cancer.

2023-07-057 citations